See a breakdown of Audience & Reach for Ken Herrmann, MD, MBA - Evolving Evidence of Radioligand Therapy in Metastatic Prostate Cancer: A 2023 Clinical Round-Up From Key Congresses
See Brand Safety for Ken Herrmann, MD, MBA - Evolving Evidence of Radioligand Therapy in Metastatic Prostate Cancer: A 2023 Clinical Round-Up From Key Congresses
How much does it cost to advertise on PeerVoice Oncology & Haematology Audio?
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More